Juniper Pharmaceuticals Inc logo

JNP - Juniper Pharmaceuticals Inc News Story

$11.5 0.0  0.0%

Last Trade - 13/08/18

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £39.4m
Position in Universe th / 6853

BRIEF-Juniper Pharmaceuticals Outlines Strategic Priorities For 2018 And Reports Recent Portfolio Progress

Tue 2nd January, 2018 9:05pm
Jan 2 (Reuters) - Juniper Pharmaceuticals Inc  JNP.O : 
    * JUNIPER PHARMACEUTICALS OUTLINES STRATEGIC PRIORITIES FOR 
2018 
AND REPORTS RECENT PORTFOLIO PROGRESS 
    * JUNIPER PHARMACEUTICALS INC - ON TRACK TO BE CASH FLOW 
POSITIVE 
IN 2018 
    * JUNIPER PHARMACEUTICALS INC - CONTINUED "STRONG" 
DOUBLE-DIGIT 
REVENUE GROWTH FOR CRINONE AND JPS EXPECTED IN 2018 
    * JUNIPER - ACTIVE DISCUSSIONS WITH MERCK KGAA TO EXTEND 
CRINONE 
PROGESTERONE GEL AGREEMENT ARE PROGRESSING 
    * JUNIPER PHARMACEUTICALS INC - PARTNERING OPPORTUNITIES ARE 
BEING 
"EXPLORED" FOR JNP-0101, THE OXYBUTYNIN IVR FOR TREATMENT OF 
OVERACTIVE BLADDER 
    * JUNIPER PHARMACEUTICALS - PARTNERING OPPORTUNITIES ARE 
BEING 
"EXPLORED" FOR JNP-0301, A NATURAL PROGESTERONE IVR FOR 
PREVENTION OF PRE-TERM BIRTH 
 
Source text for Eikon:  ID:nPn2SwkK9a  
Further company coverage:  JNP.O  
 
 ((Bangalore.newsroom@thomsonreuters.com; ;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.